Healthcare >> Analyst Interviews >> July 11, 2011
Dr. Duane Nash, M.D., is a Senior Vice President in the equity research department of Wedbush Securities, which he joined in 2009 upon Wedbush's acquisition of Pacific Growth Equities, LLC. Before joining the sell side, Dr. Nash was employed with the law firm of Davis Polk & Wardwell LLP, where he practiced intellectual property litigation, as well as patent evaluation and strategy in the merger-and-acquisition context. Previously, Dr. Nash worked at two other Bay Area law firms, and also completed his internship in general surgery at the University of California, San Francisco. He received his B.A. in biology from Williams College, his M.D. from Dartmouth Medical School, his J.D. from the University of California, Berkeley, and his MBA from the University of Oxford. Dr. Nash is a California-licensed physician and also a Member of the The State Bar of California. Profile
TWST: Where do you focus your attention in the medical devices space these days?
Dr. Nash: I focus my research in two areas: predominantly in the cardiac space, both drugs and devices; and then I am
